Skip to content
RARECast cover art

All episodes

RARECast, 618 episodes. Page 2 of 7.

#
Title
101

Finding Strength

102

A Non-Profit Works to Advance a DMD Gene Therapy

103

Accepting What We Can’t Understand

104

A Gene Therapy Company Born from a Father’s Efforts to Save his Daughter

105

Lowering Barriers to Clinical Trial Participation with Do-It-Yourself Blood Sample Collection

106

Scaling N-of-1 Therapies to Viability

107

Building Gene Therapies that Address Gain and Loss of Function Simultaneously

108

How One Woman Climbed from Patient to Advocate

109

Shortening the Diagnostic Odyssey

110

Making Exomes More Revealing

111

How One Patient Organization Catalyzed Drug Development

112

Enabling On-Demand Therapies

113

After Driving an N-of-1 Therapy for Her Son, an Advocate Turns to Helping Others

114

Putting Rare Disease Organization in the Business of Drug Development

115

Understanding the Many Questions Gene Therapies Raise

116

A Test to Identify People Likely to Develop ALS

117

How an Ultra-Rare Disease Patient Foundation Advanced a Gene Therapy

118

Making the $10 Genome a Reality

119

A No-Nonsense Effort to Develop a Therapy that Works Across Genetic Diseases

120

Mapping a Perilous Journey with Humor

121

Restoring Vision in Inherited Retinal Disease

122

Bringing Genome Sequencing to Rural Populations

123

Addressing a Blind Spot in Treatments for the Cornea

124

Taking a Different Approach to Rare Epilepsies

125

A Rare Disease Drug Developer Tries to Earn Its Stripes

126

Using Plasma to Treat Rare Diseases

127

Differentiating Gene Therapies through Regulatory Elements

128

How One Patient Organization Leverages Research Investments

129

Charging into the Storm

130

A Gene Therapy Developer that Embraces Different Models for Reaching Patients

131

Using Directed Evolution to Develop New Vectors for Genetic Medicines

132

Addressing a Shortage of Genetic Counselors with AI

133

A Small Molecule Therapy to Regenerate Muscle in People with DMD

134

Forging a Faster Path for Gene Therapies

135

Determining the Value of Rare Disease Therapies

136

Buying and Building a Gene Therapy Presence

137

A Clinical Trial Failure Derails a Promising Technology

138

Helping People with Undiagnosed Rare Diseases Find Answers

139

Speeding and Scaling the Development of Genome Editing Therapies

140

Getting a Next-Generation Genome Editing Therapy for Sickle Cell Disease Back on Track

141

Trying to Break a Leg in a Wheelchair

142

A Drug Developer that Makes Pediatric Cancers a Priority

143

Harnessing the Body’s Natural RNA Machinery to Treat Diseases

144

Targeting the Leading Cause of Death in Friedreich’s Ataxia with a Gene Therapy

145

How Inhaled mRNA May Help Rare Disease Patients Breathe Easier

146

Changing What’s Possible with Cell and Gene Therapies

147

Why Flying with a Wheelchair Is a Civil Rights Issue

148

Mapping Spheres of Influence

149

Bringing Precision to the Treatment of Rare Cancers

150

The Challenges of Developing a Therapy for Pregnant Women with A Rare Condition

151

How One Drug Developer Is Addressing Health Inequities

152

Accelerating the Development of Genetic Medicines with AI

153

Leveraging AI to Address the Neuropsychiatric Conditions Associated with a Rare Disease

154

In Pursuit of a Treatment for His Son, A Lawyer Becomes a Biotech Executive

155

In Push for Treatment, a Patient Organization Becomes a Trial Sponsor

156

Delayed Diagnosis of Rare Diseases Takes Staggering Economic Toll

157

A Cell Therapy to Control Heart-Damaging Inflammation in Duchenne

158

Stimulating the Growth of Muscle Mass in People with Neuromuscular Diseases

159

Turning Grief into Action

160

A Plea to the FDA to Give an Ultra-Rare Disease Drug a Fair Hearing

161

How the Woolly Mammoth Beat a Path to Better Gene Therapies

162

A Genetic Counselor’s Journey into Patient Advocacy

163

A Company in the Fold of Rare Disease

164

Disabling Antibodies that Drive Rare, Immunological Conditions

165

Keeping the Sentinels of the Brain Vigilant

166

Considering the Unfinished Work in Cystic Fibrosis

167

How to Advocate for Yourself as You Battle Cancer

168

Targeting Neuroinflammation to Treat ALS

169

Leveraging Community Partnerships to Address a Rare Disease Behind a Medical Mystery in New Mexico

170

Accelerating Gene Editing Therapies for Rare, Neurological Conditions

171

Inhibiting Electrical Activity in Rare, Seizure Disorders

172

Improving the Function and Usability of Clothing for People with Disabilities

173

Treating Cardiopulmonary Disease with Inhaled Targeted Therapies

174

A Patient-Driven Registry Focused on Health-Related Quality of Life Data

175

An Ally for the Undiagnosed Emerges

176

Help for Rare Disease Patients That’s Just a Click Away

177

Diagnosing Autism with a Single Strand of Hair

178

Bringing Regenerative Medicine to a Rare Bone Condition in Children

179

Bringing Precision to CRISPR-Based Genome Editing

180

Capturing Patients’ Experience in Their Daily Lives

181

From One to Many

182

A Nasal Spray to Curb Excessive Eating in Prader-Willi

183

How One Foundation Is Laying the Groundwork to Advance Treatments for an Ultra-Rare Disease

184

Forging a New Path for Medicine

185

Restoring Hearing through Gene Therapies

186

Creating a Sustainable Reimbursement Model for Ultra-Rare Therapies

187

Lumos Hopes Its Oral Alternative to HGH Will Fuel Its Growth

188

Advancing a Gene Therapy for a Rare and Fatal CNS Disorder

189

Addressing the Barriers to Patient Participation in Clinical Trials

190

A Venture Philanthropist Makes the Case for Advocates Taking Equity

191

Seeking a Sustainable Business Developing on N-of-1 Therapies

192

How One Drugmaker Reaches out to Communities at Greater Risk for Rare Heart Condition

193

A Next-Generation RNA Therapy Targets Telomere Disorders

194

BridgeBio Advances Therapy for Limb-Girdle Muscular Dystrophy that Started with Two Patient Families

195

Translating Urgency into Science

196

Empowering Ultra-Rare Disease Patients to Pursue the Discovery of Treatments

197

Why a Topical Cannabidiol Gel May Help Treat the Behavioral Symptoms of Fragile X

198

An Ultra-Rare Disease Drug Developer Tries to Navigate Regulatory Uncertainty

199

Powering Cells in People with Rare Mitochondrial Diseases

200

Powering Weakened and Stressed Cells in ALS to Function Better with Nanocrystal Therapy